Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Covalon Technologies Ltd V.COV

Alternate Symbol(s):  CVALF

Covalon Technologies Ltd. is a patient-driven medical device company. Through a portfolio of patented technologies and solutions for advanced wound care, infection prevention, and medical device coatings, the Company offers gentler and more compassionate options for patients to heal with less infections, less pain, and better outcomes. Its solutions are designed for patients and made for care providers. It leverages its patented medical technology platforms and expertise in two ways: by developing products that are sold under Covalon’s name and by developing and commercializing medical products for other medical companies under development and license contracts. It provides a range of specialized medical devices, medical dressings and advanced medical technology designed for infection prevention, complex wound closure and perioperative care. Its perioperative care solutions provide antimicrobial protection of pre-operative skin, through postoperative incision care to scar prophylaxis.


TSXV:COV - Post by User

Bullboard Posts
Comment by familyofficeguron Apr 02, 2018 9:08am
92 Views
Post# 27813570

RE:RE:RE:RE:RE:RE:RE:i will buy at 3.50, no support

RE:RE:RE:RE:RE:RE:RE:i will buy at 3.50, no supportFirst let me apologize for my mean spirited post a while back. Apologies to the person I attacked.

Yeah the air has really come out of this balloon. It's all about execution at this point. The company needs to continue to win new business and ramp product sales if the stock is going to move meaningfully higher. Gross margins remain solid, but those agency costs are really eating into the bottom-line. They need to demonstrate they can sell elsewhere and start growing profits again. The US business has some momentum but is still relatively small. I'd like to see a return to $8M or better in overall Q2 revenues.

Growth stocks rarely go up in a straight line. The momentum can return if the company continues to execute. I have owned this stock for 3+ years and have no plans to sell. Of course all that would change if I didn't feel they were going to execute their plan, but for now I still like the direction this company is headed and the products in the market and in the pipeline. Hopefully this finds a bottom soon. Best of luck to all.
Bullboard Posts